Felicia Ruffin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Felicia Ruffin has a total of 194 co-authors. Here are the top co-authors by number of shared publications:
- Vance G. Fowler
Division of Infectious Diseases, Duke University Medical Center , Durham, North Carolina
10 shared publications - Joshua T. Thaden
Division of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA
6 shared publications Heather A King
Department of Population Health Sciences, Duke University School of Medicine , Durham, North Carolina
5 shared publications- Julie Miller
Department of Population Health Sciences, Duke University School of Medicine , Durham, North Carolina
5 shared publications Megan Oakes
Department of Population Health Sciences, Duke University School of Medicine , Durham, North Carolina
5 shared publications- Sarah B. Doernberg
Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA
5 shared publications
Latest Publications
- 5 October 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Host Immune Biosignatures Predict Septic Shock and Mortality in Solid Organ Transplant Recipients With Gram-Negative Bacteremia
Background: The aim of this study was to determine whether the addition of immunologic biosignatures to a predictive model based solely on clinical data could improve the model's ability to predict patient outcome among solid organ transplant (SOT) recipients with gram-negative bacteremia (GNB). Methods: Plasma was prospectively collected from SOT recipients with GNB. Twenty-seven cytokines, chemokines, and immunoglobulin levels were quantified. Two logistic regression models were specified: a clinical model including age, transplanted organ, and time since transplant and a clinical-immunologic model that additionally incorporated the first two principal components. Model performance was evaluated using area under the curve (AUC). Internal validation was performed by repeated 10-fold cross-validation. AUCs were compared with a paired t test. Results: Of 169 SOT recipients with GNB, 45 (26.6%) experienced an adverse outcome (septic shock or death). When compared with the clinical model alone, the clinical-immunologic model demonstrated superior discrimination (AUC, 0.70 vs 0.84; P < .001). Principal component 1, characterized by broad immune dysregulation, was associated with increased risk for adverse outcome (odds ratio, 1.43; 95% CI, 1.24–1.69) and was characterized by strong contributions from innate proinflammatory mediators (TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1β, IL12p70, MIP-1α, and GMCSF), anti-inflammatory mediators (IL-10, IL-4, and IL-13), and IL-2. In contrast, principal component 2 was associated with a favorable outcome (odds ratio, 0.61; 95% CI, .43–.84) and reflected coordinated adaptive immunity, with dominant contributions from Th1, Th17, and humoral pathways (TNFβ, IFNg, IP-10, IL-17A, IgG, IgM). Conclusions: Immune biosignatures significantly improved prediction of adverse outcomes beyond clinical factors in SOT recipients with GNB.
- 5 October 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Host Immune Biosignatures Predict Septic Shock and Mortality in Solid Organ Transplant Recipients With Gram-Negative Bacteremia
Background: The aim of this study was to determine whether the addition of immunologic biosignatures to a predictive model based solely on clinical data could improve the model's ability to predict patient outcome among solid organ transplant (SOT) recipients with gram-negative bacteremia (GNB). Methods: Plasma was prospectively collected from SOT recipients with GNB. Twenty-seven cytokines, chemokines, and immunoglobulin levels were quantified. Two logistic regression models were specified: a clinical model including age, transplanted organ, and time since transplant and a clinical-immunologic model that additionally incorporated the first two principal components. Model performance was evaluated using area under the curve (AUC). Internal validation was performed by repeated 10-fold cross-validation. AUCs were compared with a paired t test. Results: Of 169 SOT recipients with GNB, 45 (26.6%) experienced an adverse outcome (septic shock or death). When compared with the clinical model alone, the clinical-immunologic model demonstrated superior discrimination (AUC, 0.70 vs 0.84; P < .001). Principal component 1, characterized by broad immune dysregulation, was associated with increased risk for adverse outcome (odds ratio, 1.43; 95% CI, 1.24–1.69) and was characterized by strong contributions from innate proinflammatory mediators (TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1β, IL12p70, MIP-1α, and GMCSF), anti-inflammatory mediators (IL-10, IL-4, and IL-13), and IL-2. In contrast, principal component 2 was associated with a favorable outcome (odds ratio, 0.61; 95% CI, .43–.84) and reflected coordinated adaptive immunity, with dominant contributions from Th1, Th17, and humoral pathways (TNFβ, IFNg, IP-10, IL-17A, IgG, IgM). Conclusions: Immune biosignatures significantly improved prediction of adverse outcomes beyond clinical factors in SOT recipients with GNB.
- Open Access
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Diabetes Unmasks the Invasive Potential of Circulating Hypermucoviscous Klebsiella Pneumoniae
Background: Klebsiella pneumoniae is a major cause of community- and healthcare-associated infections worldwide. While classical K. pneumoniae (cKp) is recognized for multidrug resistance, hypervirulent K. pneumoniae (hvKp) carries enhanced virulence traits that enable tissue-invasive disease. Testing for hvKp is not routinely performed in clinical laboratories outside Asia, raising the possibility that strains with invasive potential circulate undetected. The prevalence and invasive potential of hvKp in U.S. healthcare settings remain poorly defined. Methods: We screened 549 clinical K. pneumoniae isolates from two academic healthcare systems in North Carolina for hypermucoviscosity (HMV), a phenotypic proxy for hvKp, using a quantitative sedimentation resistance assay. HMV-positive isolates were characterized using human serum survival assays and whole-genome sequencing to identify virulence-associated genetic determinants. A subset was evaluated in a disseminating wound infection model in immunocompetent mice. Selected isolates were further tested in a diabetic mouse model to examine the impact of host metabolic status on virulence. Findings: Overall, 17 of the 549 (3·1%) K. pneumoniae isolates were HMV-positive. HMV prevalence was similar in community- versus healthcare-associated isolates (4% v. 2·1%, p=0·21), and between blood and non-blood sources (3·2% v. 3·0%, p=1·00). In an immunocompetent murine disseminating wound infection model, only a subset of HMV-positive isolates caused invasive infection. However, five HMV-positive isolates that were avirulent in immunocompetent mice became invasive in diabetic mice, demonstrating that diabetic host status can unmask invasive potential. Interpretation: HMV-positive K. pneumoniae circulate unrecognized within U.S. healthcare systems. Although HMV alone does not predict invasive disease in immunocompetent hosts, diabetic host status can unmask the invasive potential of HMV-positive isolates that otherwise appear avirulent. These findings suggest that healthy animal models may underestimate the pathogenic potential of isolates recovered from patients with diabetes and support routine HMV surveillance in clinical microbiology.
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDiabetes Unmasks the Invasive Potential of Circulating Hypermucoviscous Klebsiella Pneumoniae
Background: Klebsiella pneumoniae is a major cause of community- and healthcare-associated infections worldwide. While classical K. pneumoniae (cKp) is recognized for multidrug resistance, hypervirulent K. pneumoniae (hvKp) carries enhanced virulence traits that enable tissue-invasive disease. Testing for hvKp is not routinely performed in clinical laboratories outside Asia, raising the possibility that strains with invasive potential circulate undetected. The prevalence and invasive potential of hvKp in U.S. healthcare settings remain poorly defined. Methods: We screened 549 clinical K. pneumoniae isolates from two academic healthcare systems in North Carolina for hypermucoviscosity (HMV), a phenotypic proxy for hvKp, using a quantitative sedimentation resistance assay. HMV-positive isolates were characterized using human serum survival assays and whole-genome sequencing to identify virulence-associated genetic determinants. A subset was evaluated in a disseminating wound infection model in immunocompetent mice. Selected isolates were further tested in a diabetic mouse model to examine the impact of host metabolic status on virulence. Findings: Overall, 17 of the 549 (3·1%) K. pneumoniae isolates were HMV-positive. HMV prevalence was similar in community- versus healthcare-associated isolates (4% v. 2·1%, p=0·21), and between blood and non-blood sources (3·2% v. 3·0%, p=1·00). In an immunocompetent murine disseminating wound infection model, only a subset of HMV-positive isolates caused invasive infection. However, five HMV-positive isolates that were avirulent in immunocompetent mice became invasive in diabetic mice, demonstrating that diabetic host status can unmask invasive potential. Interpretation: HMV-positive K. pneumoniae circulate unrecognized within U.S. healthcare systems. Although HMV alone does not predict invasive disease in immunocompetent hosts, diabetic host status can unmask the invasive potential of HMV-positive isolates that otherwise appear avirulent. These findings suggest that healthy animal models may underestimate the pathogenic potential of isolates recovered from patients with diabetes and support routine HMV surveillance in clinical microbiology.
- Open Access
- 25 March 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (4) , 332
Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia
Background: Staphylococcus aureus bacteremia (SAB) is a common and life-threatening bloodstream infection often caused by methicillin-resistant SA (MRSA) isolates. Up to 35% of SAB patients fail to clear infection with gold-standard anti-MRSA antibiotics, even if the isolate meets susceptibility breakpoints in conventional assays in vitro. Such outcomes are termed persistent and may involve small colony variant (SCV) adaptation of SA in vivo. Methods: In this study, we assessed virulence phenotypes and mechanisms in persistent (PB) vs. resolving (RB) MRSA isolates from SAB. Results: Overall, PB isolates caused less hemolysis or biofilm formation than RB isolates, but proteolysis was equivalent. Attenuation of these virulence phenotypes increased longitudinally during the course of SAB. Although PB vs. RB isolates had similar human endothelial cell invasion rates, PB isolates more frequently formed SCVs intracellularly and inversely correlated with pH. Study PB and RB isolates exhibited distinct susceptibilities to prototypic human host defense peptides (HDPs), which were influenced by antibiotics and pH. Furthermore, mechanistic signatures of HDPs differed between PB and RB isolates. Conclusions: Together, these results reveal that MRSA isolates from PB vs. RB outcomes of SAB have differential virulence profiles that suggest coordinated immune subversion in PB. Understanding MRSA adaptations that promote persistence in SAB may enable innovative agents and strategies to address these challenging infections.
- 25 March 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (4) , 332
Open AccessVirulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia
Background: Staphylococcus aureus bacteremia (SAB) is a common and life-threatening bloodstream infection often caused by methicillin-resistant SA (MRSA) isolates. Up to 35% of SAB patients fail to clear infection with gold-standard anti-MRSA antibiotics, even if the isolate meets susceptibility breakpoints in conventional assays in vitro. Such outcomes are termed persistent and may involve small colony variant (SCV) adaptation of SA in vivo. Methods: In this study, we assessed virulence phenotypes and mechanisms in persistent (PB) vs. resolving (RB) MRSA isolates from SAB. Results: Overall, PB isolates caused less hemolysis or biofilm formation than RB isolates, but proteolysis was equivalent. Attenuation of these virulence phenotypes increased longitudinally during the course of SAB. Although PB vs. RB isolates had similar human endothelial cell invasion rates, PB isolates more frequently formed SCVs intracellularly and inversely correlated with pH. Study PB and RB isolates exhibited distinct susceptibilities to prototypic human host defense peptides (HDPs), which were influenced by antibiotics and pH. Furthermore, mechanistic signatures of HDPs differed between PB and RB isolates. Conclusions: Together, these results reveal that MRSA isolates from PB vs. RB outcomes of SAB have differential virulence profiles that suggest coordinated immune subversion in PB. Understanding MRSA adaptations that promote persistence in SAB may enable innovative agents and strategies to address these challenging infections.
- Open Access
- 27 January 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 392-403
Genetics and environment distinctively shape the human immune cell epigenome
The epigenome of human immune cells is shaped by both genetics and environmental factors, yet the relative contributions of these influences remain incompletely characterized. Here we use single-nucleus methylation sequencing and assay for transposase-accessible chromatin using sequencing (ATAC–seq) to systematically explore how pathogen and chemical exposures, along with genetic variation, are associated with changes in the immune cell epigenome. Distinct exposure-associated differentially methylated regions (eDMRs) and differentially accessible regions were identified, and a significant correlation between these two modalities was observed. Additionally, genotype-associated DMRs (gDMRs) were detected, indicating that eDMRs are enriched in regulatory regions, whereas gDMRs are preferentially located within gene body marks. Disease-associated single-nucleotide polymorphisms were frequently colocalized with methylation quantitative trait loci, providing cell-type-specific insights into the genetic basis of diseases. These findings highlight the complex interplay between genetic and environmental factors in shaping the immune cell epigenome and advance understanding of immune cell regulation in health and disease.
- 27 January 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 392-403
Open AccessGenetics and environment distinctively shape the human immune cell epigenome
The epigenome of human immune cells is shaped by both genetics and environmental factors, yet the relative contributions of these influences remain incompletely characterized. Here we use single-nucleus methylation sequencing and assay for transposase-accessible chromatin using sequencing (ATAC–seq) to systematically explore how pathogen and chemical exposures, along with genetic variation, are associated with changes in the immune cell epigenome. Distinct exposure-associated differentially methylated regions (eDMRs) and differentially accessible regions were identified, and a significant correlation between these two modalities was observed. Additionally, genotype-associated DMRs (gDMRs) were detected, indicating that eDMRs are enriched in regulatory regions, whereas gDMRs are preferentially located within gene body marks. Disease-associated single-nucleotide polymorphisms were frequently colocalized with methylation quantitative trait loci, providing cell-type-specific insights into the genetic basis of diseases. These findings highlight the complex interplay between genetic and environmental factors in shaping the immune cell epigenome and advance understanding of immune cell regulation in health and disease.
- Open Access
- 27 November 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 82 (4) , e643-e651
Reproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes
Background: Clinical heterogeneity in Staphylococcus aureus bacteremia (SAB) complicates clinical management and research. We have previously identified 5 clinically distinct subphenotypes of SAB associated with differences in outcomes and response to adjunctive rifampicin. Here, we aimed to identify these subphenotypes in geographically diverse observational cohorts, including a higher prevalence of methicillin-resistant S. aureus (MRSA) bacteremia and the USA300 clone. Methods: We studied 3 cohorts of adults with SAB from observational studies: a UK retrospective study (Edinburgh cohort 2; n = 463); a Dutch prospective study (IDISA [Improved Diagnostic Strategies in Staphylococcus aureus bacteremia study]; n = 490); and a prospective US study (SABG-PCS [Staphylococcus aureus Bacteremia Group Prospective Cohort Study]; n = 755). Subphenotypes were identified from routinely available clinical data using latent class analysis. Results: Patients from the SABG-PCS cohort had greater multimorbidity and more MRSA bacteremia (40.2% [303 of 755]), including infection with the USA300 clone (14.7% [111 of 755]). Five distinct subphenotypes were identified in each cohort: (1) older age and cardiometabolic multimorbidity; (2) nosocomial acquisition and intravenous catheter portal of entry; (3) community acquisition and metastatic infection; (4) chronic kidney disease; and (5) younger age, injection drug use, and metastatic infection. Bacterial genotypes varied substantially between the Edinburgh 2 and SABG-PCS cohorts but did not differ between subphenotypes within each cohort. 90-day mortality was highest in subphenotype A, and persistent bacteremia in subphenotypes C and E. Conclusions: We have reproducibly identified 5 clinical subphenotypes of SAB in observational cohorts including diverse bacterial genetic lineages and a cohort with a high prevalence of MRSA and USA300 bacteremia. These robustly reproducible clinical subphenotypes provide a framework to rationalize the heterogeneity intrinsic to SAB.
- 27 November 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 82 (4) , e643-e651
Open AccessReproducible Identification of Staphylococcus aureus Bacteremia Clinical Subphenotypes
Background: Clinical heterogeneity in Staphylococcus aureus bacteremia (SAB) complicates clinical management and research. We have previously identified 5 clinically distinct subphenotypes of SAB associated with differences in outcomes and response to adjunctive rifampicin. Here, we aimed to identify these subphenotypes in geographically diverse observational cohorts, including a higher prevalence of methicillin-resistant S. aureus (MRSA) bacteremia and the USA300 clone. Methods: We studied 3 cohorts of adults with SAB from observational studies: a UK retrospective study (Edinburgh cohort 2; n = 463); a Dutch prospective study (IDISA [Improved Diagnostic Strategies in Staphylococcus aureus bacteremia study]; n = 490); and a prospective US study (SABG-PCS [Staphylococcus aureus Bacteremia Group Prospective Cohort Study]; n = 755). Subphenotypes were identified from routinely available clinical data using latent class analysis. Results: Patients from the SABG-PCS cohort had greater multimorbidity and more MRSA bacteremia (40.2% [303 of 755]), including infection with the USA300 clone (14.7% [111 of 755]). Five distinct subphenotypes were identified in each cohort: (1) older age and cardiometabolic multimorbidity; (2) nosocomial acquisition and intravenous catheter portal of entry; (3) community acquisition and metastatic infection; (4) chronic kidney disease; and (5) younger age, injection drug use, and metastatic infection. Bacterial genotypes varied substantially between the Edinburgh 2 and SABG-PCS cohorts but did not differ between subphenotypes within each cohort. 90-day mortality was highest in subphenotype A, and persistent bacteremia in subphenotypes C and E. Conclusions: We have reproducibly identified 5 clinical subphenotypes of SAB in observational cohorts including diverse bacterial genetic lineages and a cohort with a high prevalence of MRSA and USA300 bacteremia. These robustly reproducible clinical subphenotypes provide a framework to rationalize the heterogeneity intrinsic to SAB.
- 8 September 2025
- Published by American Nurses Association in OJIN: The Online Journal of Issues in Nursing
- Vol. 30 (3)
Health Policy Impact on Healthcare-Associated Infections and Nurses’ Responsibilities for Professional Awareness and Engagement
A significant public health concern is healthcare-associated infections (HAIs) prevalent in hospitals, nursing homes, and outpatient treatment centers. HAIs threaten staff and patient safety. Reducing and eliminating HAIs can save lives and reduce healthcare costs. Legislators and healthcare professionals are significant in developing health policies to reduce HAIs and improve patient care quality. Policies combat this problem by establishing mandatory surveillance programs funded by the state and federal governments. Health policy also governs HAIs through payment systems to encourage best practices for preventing HAIs. Various methods are used to determine if outcomes, e.g., lower rates of infections, are attributable to the policies. Nurses play a vital role in shaping health policy through professional awareness, research, leadership, and engagement.
- 8 September 2025
- Published by American Nurses Association in OJIN: The Online Journal of Issues in Nursing
- Vol. 30 (3)
Health Policy Impact on Healthcare-Associated Infections and Nurses’ Responsibilities for Professional Awareness and Engagement
A significant public health concern is healthcare-associated infections (HAIs) prevalent in hospitals, nursing homes, and outpatient treatment centers. HAIs threaten staff and patient safety. Reducing and eliminating HAIs can save lives and reduce healthcare costs. Legislators and healthcare professionals are significant in developing health policies to reduce HAIs and improve patient care quality. Policies combat this problem by establishing mandatory surveillance programs funded by the state and federal governments. Health policy also governs HAIs through payment systems to encourage best practices for preventing HAIs. Various methods are used to determine if outcomes, e.g., lower rates of infections, are attributable to the policies. Nurses play a vital role in shaping health policy through professional awareness, research, leadership, and engagement.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S16-S23
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections
Background: Complicated urinary tract infections (cUTIs) significantly affect patients’ health-related quality of life (HRQoL), yet current end points defined by the United States Food and Drug Administration for antibiotic registrational trials fail to capture important elements of the patient experience with cUTI. In this systematic review, we aimed to identify measurement tools for HRQoL that have been studied in patients with cUTIs. Methods: Following a prospectively registered protocol in PROSPERO (CRD42020215641), English-language articles were queried using MEDLINE (via PubMed), Embase (Elsevier), and CINAHL (EBSCO) from database inception to 12 October 2022. Results: We identified 24 articles (96% rated as high quality) with 22 distinct measures. Overall, 45% of measures were categorized as generic and 27% as condition-specific; 27% were developed by researchers. Qualitative studies provided details regarding patient experience across multiple HRQoL domains. Conclusions: Our results add to the limited literature on HRQoL measures studied in cUTI and emphasize the importance of standardization, development, and validation of instruments to incorporate patients’ voices into novel trial end points for cUTI.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S16-S23
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections
Background: Complicated urinary tract infections (cUTIs) significantly affect patients’ health-related quality of life (HRQoL), yet current end points defined by the United States Food and Drug Administration for antibiotic registrational trials fail to capture important elements of the patient experience with cUTI. In this systematic review, we aimed to identify measurement tools for HRQoL that have been studied in patients with cUTIs. Methods: Following a prospectively registered protocol in PROSPERO (CRD42020215641), English-language articles were queried using MEDLINE (via PubMed), Embase (Elsevier), and CINAHL (EBSCO) from database inception to 12 October 2022. Results: We identified 24 articles (96% rated as high quality) with 22 distinct measures. Overall, 45% of measures were categorized as generic and 27% as condition-specific; 27% were developed by researchers. Qualitative studies provided details regarding patient experience across multiple HRQoL domains. Conclusions: Our results add to the limited literature on HRQoL measures studied in cUTI and emphasize the importance of standardization, development, and validation of instruments to incorporate patients’ voices into novel trial end points for cUTI.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S32-S39
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia
Background: We conducted a systematic review to gain insight into how health-related quality of life (HRQoL) is measured and reported in hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), common causes of disease and death in hospitalized patients. Methods: Following a prospectively registered protocol in PROSPERO (CRD42021253579), we searched electronic databases, including MEDLINE (PubMed), EMBASE (Elsevier), and CINAHL (EBSCO) from database inception through October 2022 to identify studies measuring HRQoL in patients with HABP and/or VABP. Results: Of 2633 studies identified, 5 articles met our inclusion criteria. Of the 5 included studies, 3 were performed in patients with traumatic brain injury; 4 studies were conducted at a single hospital site, and 1 was from a multicenter registry. Measures to assess HRQoL varied between studies and primarily included the Glasgow Outcome Scale–Extended and the 36-item Short Form. All studies were of mid- to high quality and concluded that HABP/VABP decreased multiple domains of HRQoL, although it was difficult to determine whether this was below the background decrease in HRQoL for comorbid medical conditions. Conclusions: Overall, there is limited measurement of HRQoL in patients with HABP/VABP; however, existing data indicate that HABP/VABP impairs multiple domains of HRQoL. More research is needed to standardize measurements of HRQoL and its application in patients with HABP/VABP.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S32-S39
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia
Background: We conducted a systematic review to gain insight into how health-related quality of life (HRQoL) is measured and reported in hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), common causes of disease and death in hospitalized patients. Methods: Following a prospectively registered protocol in PROSPERO (CRD42021253579), we searched electronic databases, including MEDLINE (PubMed), EMBASE (Elsevier), and CINAHL (EBSCO) from database inception through October 2022 to identify studies measuring HRQoL in patients with HABP and/or VABP. Results: Of 2633 studies identified, 5 articles met our inclusion criteria. Of the 5 included studies, 3 were performed in patients with traumatic brain injury; 4 studies were conducted at a single hospital site, and 1 was from a multicenter registry. Measures to assess HRQoL varied between studies and primarily included the Glasgow Outcome Scale–Extended and the 36-item Short Form. All studies were of mid- to high quality and concluded that HABP/VABP decreased multiple domains of HRQoL, although it was difficult to determine whether this was below the background decrease in HRQoL for comorbid medical conditions. Conclusions: Overall, there is limited measurement of HRQoL in patients with HABP/VABP; however, existing data indicate that HABP/VABP impairs multiple domains of HRQoL. More research is needed to standardize measurements of HRQoL and its application in patients with HABP/VABP.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S48-S54
A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection
Background: Despite the prevalence of intra-abdominal infections, urinary tract infections, and skin/skin structure infections, the relative impact of these syndromes on patient health-related quality of life (HRQoL) is unclear. This qualitative secondary analysis used data from an interview-based HRQoL qualitative study of bloodstream infections by source of infection to inform the potential development, adaptation, and use of HRQoL measures. Methods: Interview transcripts from eligible participants (aged ≥18 years) with intra-abdominal, urinary tract, and skin/skin structure infections as the source of bloodstream infection were selected from parent study data collected between May 2017 and September 2018. Interviews were conducted at 6 to 8 weeks postdischarge with participants enrolled at a single, tertiary academic medical center in the United States. We assessed patients' perspectives using episode profile and content analysis to identify key concepts that impacted HRQoL during the course of illness, treatment, and follow-up care. Results: We analyzed 31 interview transcripts and identified 6 key concepts with a short- or long-term impact on HRQoL: (1) preinfection characteristics, (2) self-management after discharge, (3) overall health context, (4) fear of recurrent infection, (5) social support and caregivers' availability, and (6) follow-up and recovery. The concepts' impact varied by syndrome. Conclusions: Patient-reported perspectives expanded our understanding of the experiences of patients with bloodstream infections by source of infection. Future studies will require measuring patient-reported HRQoL in a way that captures what is meaningful to patients with different types of infection.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S48-S54
A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection
Background: Despite the prevalence of intra-abdominal infections, urinary tract infections, and skin/skin structure infections, the relative impact of these syndromes on patient health-related quality of life (HRQoL) is unclear. This qualitative secondary analysis used data from an interview-based HRQoL qualitative study of bloodstream infections by source of infection to inform the potential development, adaptation, and use of HRQoL measures. Methods: Interview transcripts from eligible participants (aged ≥18 years) with intra-abdominal, urinary tract, and skin/skin structure infections as the source of bloodstream infection were selected from parent study data collected between May 2017 and September 2018. Interviews were conducted at 6 to 8 weeks postdischarge with participants enrolled at a single, tertiary academic medical center in the United States. We assessed patients' perspectives using episode profile and content analysis to identify key concepts that impacted HRQoL during the course of illness, treatment, and follow-up care. Results: We analyzed 31 interview transcripts and identified 6 key concepts with a short- or long-term impact on HRQoL: (1) preinfection characteristics, (2) self-management after discharge, (3) overall health context, (4) fear of recurrent infection, (5) social support and caregivers' availability, and (6) follow-up and recovery. The concepts' impact varied by syndrome. Conclusions: Patient-reported perspectives expanded our understanding of the experiences of patients with bloodstream infections by source of infection. Future studies will require measuring patient-reported HRQoL in a way that captures what is meaningful to patients with different types of infection.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S24-S31
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections
Background: Acute bacterial skin and skin structure infections (ABSSSIs) can diminish patients’ health-related quality of life (HRQoL). We performed a systematic review to determine how HRQoL has been measured in patients with ABSSSIs. Methods: We searched MEDLINE (PubMed), Embase (Elsevier), and CINAHL (EBSCO) for articles published between database inception and 14 October 2022, following a prospectively registered protocol in PROSPERO (CRD42021225414). Results: We identified 37 articles that employed 42 distinct measures: 26 generic measures assessing HRQoL; 14 condition-specific measures, including repurposed dermatologic or surgical HRQoL measures; and 2 author-developed questionnaires assessing treatment-related HRQoL. We found reduced HRQoL for patients experiencing ABSSSIs, which usually exhibited rapid onset and resolution. Pain had the greatest negative impact on HRQoL, and the most common HRQoL domain impacted was physical functioning. Conclusions: Progress has been made in the development and use of HRQoL measures, yet we did not identify a repurposed or novel tool that best captures HRQoL in patients with ABSSSI.
- 6 August 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (Supplement) , S24-S31
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections
Background: Acute bacterial skin and skin structure infections (ABSSSIs) can diminish patients’ health-related quality of life (HRQoL). We performed a systematic review to determine how HRQoL has been measured in patients with ABSSSIs. Methods: We searched MEDLINE (PubMed), Embase (Elsevier), and CINAHL (EBSCO) for articles published between database inception and 14 October 2022, following a prospectively registered protocol in PROSPERO (CRD42021225414). Results: We identified 37 articles that employed 42 distinct measures: 26 generic measures assessing HRQoL; 14 condition-specific measures, including repurposed dermatologic or surgical HRQoL measures; and 2 author-developed questionnaires assessing treatment-related HRQoL. We found reduced HRQoL for patients experiencing ABSSSIs, which usually exhibited rapid onset and resolution. Pain had the greatest negative impact on HRQoL, and the most common HRQoL domain impacted was physical functioning. Conclusions: Progress has been made in the development and use of HRQoL measures, yet we did not identify a repurposed or novel tool that best captures HRQoL in patients with ABSSSI.